EP Patent

EP3091084A1 — Methods for assessing the purity of a mesenchymal stem cells preparation

Assigned to Universite Catholique de Louvain UCL · Expires 2016-11-09 · 10y expired

What this patent protects

The present invention relates to a method for assessing, evaluating and/monitoring the purity of a mesenchymal stem cells preparation, in particular of an adipose stem cells preparation, comprising measuring the expression level of at least one growth factor.

USPTO Abstract

The present invention relates to a method for assessing, evaluating and/monitoring the purity of a mesenchymal stem cells preparation, in particular of an adipose stem cells preparation, comprising measuring the expression level of at least one growth factor.

Drugs covered by this patent

Patent Metadata

Patent number
EP3091084A1
Jurisdiction
EP
Classification
—
Expires
2016-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Universite Catholique de Louvain UCL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.